Showing results (1581-1590 of 1,659) with videos related to
Sort By:
Pageof 166
Molecular Metabolism|March 12, 2018
Skeletal muscle O-GlcNAc transferase is important for muscle energy homeostasis and whole-body insulin sensitivityHao Shi, Alexander Munk, Thomas S Nielsen, et al.Molecular Metabolism|November 30, 2025
Effects of CT-388, a once-weekly signaling-biased dual GLP-1/GIP receptor agonist, on weight loss and glycemic control in preclinical models and participants with obesityManu V Chakravarthy, Ruben Rodriguez, Anne Hergarden, et al.Cancers|October 14, 2023
Patient-Reported Outcomes among Multiple Myeloma Patients Treated with Standard of Care Idecabtagene VicleucelLaura B Oswald, Lisa M Gudenkauf, Xiaoyin Li, et al.Archives of Osteoporosis|August 24, 2023
Validation of forearm fracture diagnoses in administrative patient registersTone Kristin Omsland, Lene B Solberg, Åshild Bjørnerem, et al.Journal of the American Chemical Society|August 17, 2023
Tailored Chemical Reactivity Probes for Systemic Imaging of Aldehydes in Fibroproliferative DiseasesHua Ma, Iris Y Zhou, Y Iris Chen, et al.Cancer Chemotherapy and Pharmacology|August 4, 2009
SNS-314, a pan-Aurora kinase inhibitor, shows potent anti-tumor activity and dosing flexibility in vivoJennifer P Arbitrario, Brian J Belmont, Marc J Evanchik, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2023
Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T ConsortiumDoris K Hansen, Surbhi Sidana, Lauren C Peres, et al.ACS Central Science|June 1, 2022
Development of a First-in-Class Small-Molecule Inhibitor of the C-Terminal Hsp90 DimerizationSanil Bhatia, Lukas Spanier, David Bickel, et al.Brain : a Journal of Neurology|November 17, 2023
Impaired cholinergic integrity of the colon and pancreas in dementia with Lewy bodiesNiels Okkels, Jacob Horsager, Tatyana D Fedorova, et al.European Journal of Haematology|May 18, 2026
Condensed vs. Standard Step-Up Dosing Schedule of Talquetamab in Relapsed/Refractory Multiple MyelomaGrace Elsey, James A Davis, Kelley Julian, et al.Pageof 166